Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 1060-1066

  Rabben, Toril ^a   Skjelbred, Per ^c   ØYe, Ivar ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PETHIDINE;

ADULT; AGED; ANALGESIA; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MENTAL DISEASE; NOCICEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; KETAMINE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032902566     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Coderre TJ, Katz J, Vaccarino AL and Melzack R (1993) Contribution of central neuroplasticity to pathological pain: A review of clinical and experimental evidence. Pain 52:259-285.
2. Collingridge G and Singer W (1990) Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sci 11:290-296.
3. Davies SN and Lodge D (1987) Evidence for involvement of N-methyl-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 424:402-406.
4. Dickenson AH (1990) A cure for wind-up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol Sci 11:307-309.
5. Dickenson AH (1994) NMDA receptor antagonists as analgesics, in Progress in Pain Research and Management (Fields HL and Liebeskind JC eds) vol 1, pp 173-187, IASP Press, Seattle.
6. Dickenson AH, Chapman V and Green GM (1997) The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol 28:633-638.
7. Dickenson SN and Sullivan AF (1987) Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fibre stimulation. Neuropharmacology 26:1235-1238.
8. Domino EF, Chodoff P and Crossen G (1965) Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther 6:279-291.
9. Grant IS, Nimmo WS and Clements JA (1981) Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 53:805-810.
10. Hartvig P, Valtysson J, Lindner KJ, Kristensen J, Karlsten R, Gustafsson LL, Persson J, Svensson JO, Øye I, Antoni G, Westerberg G and Långstrøm B (1995) Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther 58:165-173.
11. Hoffmann V, Coppejans H, Vercauteren M and Adriaemsen H (1994) Successful treatment of postherpetic neuralgia with oral ketamine. Clin J Pain 10:240-242.
12. Klepstad P and Borchgrevink PC (1997) Four years treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Acta Anaesthesiol Scand 41:422-426.
13. Klepstad P, Maurset A, Moberg ER and Øye I (1990) Evidence for a role for NMDA receptors in pain perception. Eur J Pharmacol 187:513-518.
14. Lahti A, Koffel B, Laporte D and Tamminga C (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19.
15. Lodge D and Johnson KM (1990) Noncompetitive excitatory amino acid antagonists. Trends Pharmacol Sci 11:81-86.
16. Marbach JJ (1978) Phantom tooth pain. J Endod 4:362-372.
17. Mathisen LC, Skjelbred P, Skoglund LA and Øye I (1995) Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61:215-220.
18. Maurset A, Skoglund LA, Hustveit O and Øye I (1989) Comparison of ketamine and pethidine in experimental and postoperative pain. Pain 36:37-41.
19. Meller ST (1996) Ketamine: Relief from chronic pain through actions at the NMDA receptor? Pain 68:435-436.
20. Merskey H and Bogduk N (1994) Classification of Chronic Pain, International Association for the Study of Pain, IASP Press, Seattle.
21. Øye I, Hustveit O, Maurset A, Moberg ER, Paulsen O and Skoglund LA (1991) The chiral forms of ketamine as probes for NMDA receptor function in humans, in NMDA Receptor Related Agents; Biochemistry, Pharmacology and Behavior (Kameyama T, Nabeshima T and Domino EF eds) pp 381-399, NPP Books, Ann Arbor.
22. Øye I, Paulsen O and Maurset A (1992) Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213.
23. Øye I, Rabben T and Fagerlund TH (1996) Analgesic effect of ketamine, an NMDA receptor antagonist, in a patient with neuropathic pain. J Norw Med Assoc 116: 3130-3131.
24. Sørensen J, Bengtsson A, Ahlner J, Henriksson KG, Ekselius L and Bengtsson M (1997) Fibromyalgia - are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. J Rheumatol 24:1615-1621.
25. Woolf CJ and Thompson SWN (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: Implications for the treatment of post-injury pain hypersensitivity states. Pain 44:293-299.